Lunch and Focused Sessions – Block V of V

Concurrent Events

• 01:00 PM - 01:40 PM

  AI Diagnostics | Is the Future of Diagnostics Moving “In Silico”?

  Moderator

  Danielle Bitterman, MD,

  Radiation Oncologist, Brigham and Women's Hospital;

  Assistant Professor of Radiation Oncology, Harvard Medical School

  Speakers

  Andy Beck, MD, PhD,

  CEO, PathAI

  Jacob Donoghue, MD, PhD,

  CEO, Beacon Biosignals

  Connie Lehman, MD, PhD,

  Founder, Clairity;

  Professor of Radiology, Harvard Medical School

  Jay Rughani,

  Investing Partner, Andreessen Horowitz

  David Spetzler, PhD,

  President, Caris Life Sciences

• 01:00 PM - 01:40 PM

  Tackling High Priority Health Challenges in Our Communities

  Moderator

  Elsie Taveras, MD,

  Chief Community Health & Health Equity Officer, Mass General Brigham;

  Executive Director, Kraft Center for Community Health;

  Conrad Taff Endowed Chair and Professor of Pediatrics, Harvard Medical School

  Speakers

  Alisha Lalani,

  Chief Growth Officer, Mae Health

  Kwamane Liddell,

  Founder & CEO, ThriveLink

  Christopher Thompson,

  Founder, Sober Sidekick

  Jeffrey Yang, MD,

  Thoracic Surgeon; Founding Director, Center for Artificial Intelligence & Innovation Research, Mass General Brigham;

  Associate Professor of Surgery, Harvard Medical School

• 01:00 PM - 01:40 PM

  Upending the US Care Delivery and Medical Research Model | Planning for Excellence After the Cuts

  Moderator

  Niyum Gandhi,

  CFO & Treasurer, Mass General Brigham

  Speakers

  Kiame Mahaniah, MD,

  Secretary of Health and Human Services, Commonwealth of Massachusetts

  John Orsini,

  EVP & CFO, Northwestern Memorial HealthCare

  Laura Peabody,

  Chief Legal Officer, Mass General Brigham

• 01:00 PM - 01:40 PM

  Institutional Investor LP Perspective | Opportunities & Challenges in Today’s Healthcare Investment Landscape

  Moderator

  Emma Somers-Roy,

  Chief Investment Officer, Mass General Brigham

  Speakers

  Letitia Johnson,

  Chief Investment Officer, Amherst College

  Paul Mace,

  Managing Director, Williams College Investment Office

  Adam Posner,

  Co-Head of Public Markets, HighVista Strategies

• 01:00 PM - 01:40 PM

  Picasso Ballroom

  Emerging Treatments

  Emerging Treatments | Hematological Cancers

  Moderators

  Tim Anderson, MD,

  Pharmaceutical Analyst, BofA Securities

  Alec Stranahan,

  SMid-Cap Biotech Analyst, BofA Securities

  Speakers

  Amir Fathi, MD,

  Director, Leukemia Program, Massachusetts General Hospital;

  Associate Professor of Medicine, Harvard Medical School

  Connor Johnson, MD,

  Assistant Professor of Medicine, Massachusetts General Hospital & Harvard Medical School

  Rosanna Ricafort, MD

  VP, Head of Global Program Leadership, Hematology and Cell Therapy Drug Development, Bristol Myers Squibb

  Andrew Yee, MD,

  Clinical Director, Center for Multiple Myeloma, Mass General Cancer Center,

  Assistant Professor of Medicine, Harvard Medical School